Mereo BioPharma Group plc (MREO)
USD 3.31
(-2.65%)
USD 3.31
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10 Million | 1.5 Million | 36.46 Million | 393 Thousand | -122 Thousand | - |
| Cost of Revenue | 2.57 Million | 936 Thousand | 17.9 Million | 16.34 Million | 23.6 Million | 22.7 Million |
| Gross Profit | 7.42 Million | 571 Thousand | 18.55 Million | -15.95 Million | -23.73 Million | -22.7 Million |
| Operating Expenses | 35.84 Million | 44.5 Million | 39.49 Million | 21.22 Million | 15.9 Million | 12.5 Million |
| Selling, General and Administrative Expenses | 18.42 Million | 19.54 Million | 15.93 Million | 21.22 Million | 15.9 Million | 12.5 Million |
| Research and Development Expenses | 17.41 Million | 24.96 Million | 23.55 Million | -16.34 Million | -23.6 Million | 22.7 Million |
| Other Expenses | - | 811 Thousand | - | - | - | - |
| Cost and Expenses | 38.41 Million | 43.56 Million | 57.4 Million | 37.56 Million | 39.51 Million | 35.2 Million |
| Operating Income | -28.41 Million | -43.56 Million | -20.93 Million | -37.56 Million | -39.51 Million | -35.2 Million |
| Interest Expense | 2.88 Million | 3.36 Million | 4 Million | 6.38 Million | 3.49 Million | 2.36 Million |
| Income Tax Expense | -532 Thousand | -1.89 Million | 1.51 Million | -2.82 Million | -6.27 Million | -5.27 Million |
| Earnings before Tax | -29.99 Million | -36.09 Million | 14.24 Million | -166.45 Million | -41.11 Million | -37.3 Million |
| Net Income | -29.46 Million | -34.19 Million | 12.72 Million | -163.62 Million | -34.84 Million | -32.02 Million |
| Earnings Per Share Basic | -0.04 | -0.06 | 0.02 | -0.48 | -0.39 | -0.45 |
| Earnings Per Share Diluted | -0.04 | -0.06 | 0.02 | -0.48 | -0.39 | -0.45 |
| Weighted Average Shares Outstanding | 659.45 Million | 603.19 Million | 527.81 Million | 337.71 Million | 89.34 Million | 71.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 659.45 Million | 603.19 Million | 555.27 Million | 338.95 Million | 89.42 Million | 71.14 Million |
| Gross Margin | 0.74 | 0.38 | 0.51 | -40.60 | 194.51 | - |
| EBIT Margin | -2.61 | -27.91 | -0.56 | -95.48 | 307.89 | - |
| Profit Margin | -2.95 | -22.69 | 0.35 | -416.36 | 285.61 | - |
| EBITDA | -26.05 Million | -42.06 Million | -5 Million | -37.52 Million | -37.56 Million | -34.86 Million |
| Earnings Before Tax Margin | -2.84 | -28.91 | -0.57 | -95.60 | 323.91 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 361.1 Thousand | 10 Million | 533.42 Thousand | 8.79 Million |
| Cost of Revenue | 257.28 Thousand | 274.84 Thousand | 216.92 Thousand | 2.57 Million | 172.89 Thousand | 3.52 Million |
| Gross Profit | -257.28 Thousand | -274.84 Thousand | 144.17 Thousand | 7.42 Million | 360.53 Thousand | 5.26 Million |
| Operating Expenses | 12.57 Million | 9.9 Million | 6.39 Million | 34.56 Million | 7.03 Million | 21.01 Million |
| Selling, General and Administrative Expenses | 7.61 Million | 5.9 Million | 2.45 Million | - | 2.77 Million | 11.27 Million |
| Research and Development Expenses | 4.95 Million | 3.99 Million | 2.88 Million | - | 3.18 Million | 9.73 Million |
| Other Expenses | -369 Thousand | - | - | -10 Thousand | - | - |
| Cost and Expenses | 12.82 Million | 9.9 Million | 6.61 Million | 37.13 Million | 7.2 Million | 24.54 Million |
| Operating Income | -12.82 Million | -9.9 Million | -5.69 Million | -28.41 Million | -6.16 Million | -15.75 Million |
| Interest Expense | 331 Thousand | -310 Thousand | -4.24 Million | 2.88 Million | - | 1.36 Million |
| Income Tax Expense | -369.41 Thousand | -476.72 Thousand | 244.46 Thousand | -532 Thousand | 235.58 Thousand | -1.11 Million |
| Earnings before Tax | -12.63 Million | -8.95 Million | -5.8 Million | -29.99 Million | -6.32 Million | -14.72 Million |
| Net Income | -12.26 Million | -8.95 Million | -6.04 Million | -29.46 Million | -6.55 Million | -13.6 Million |
| Earnings Per Share Basic | -0.09 | -0.01 | -0.01 | - | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.09 | -0.01 | -0.01 | - | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 142.35 Million | 700.26 Million | 691.83 Million | 659.45 Million | 691.83 Million | 551.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 142.35 Million | 700.26 Million | 691.82 Million | 659.45 Million | 691.82 Million | 627.08 Million |
| Gross Margin | - | - | 0.40 | 0.74 | 0.68 | 0.60 |
| EBIT Margin | - | - | -15.24 | - | -11.19 | -1.74 |
| Profit Margin | - | - | -16.74 | -2.95 | -12.30 | -1.55 |
| EBITDA | -12.57 Million | -9.9 Million | -5.5 Million | - | -5.96 Million | -15.25 Million |
| Earnings Before Tax Margin | - | - | -15.77 | -2.84 | -11.56 | -1.79 |
SCHW
JCHAC
SAREGAMA
603867
2185
DKS